Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance ...

He engineered a new antibody in which each arm of the Y recognized one half of the anti-RSV signature. Scharffenberger then ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

but we’ve got some new armor this year.” Dr. Dailya Khuon, a pediatric infectious disease physician at Helen DeVos Children’s Hospital, said RSV will affect about 90% of children by the time ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In May, the FDA approved the mRNA-1345 RSV vaccine (mResvia) from Moderna for people ages 60 and older to protect ...

This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for seniors. RSV is a virus that can cause lung and respiratory tract ...

This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for seniors. Carina Marquez, MD, associate professor of Medicine in ...